Search
for
Sort by
Research 931–960 of 1000+
- The association between serum zinc levels and subjective symptoms in zinc deficiency patients with chronic liver disease
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- The Association of Serum Adipokines, Insulin Resistance and Vitamin D Status in Male Patients with Androgenetic Alopecia
- Keratin 15 Expression in Stratified Epithelia: Downregulation in Activated Keratinocytes
- Microbiome in the hair follicle of androgenetic alopecia patients
- Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17/TH22 skewing
- An essential role for <i>Rxrα</i> in the development of Th2 responses
- Alopecia Universalis Following Two Sequential Traffic Accidents : Possible Association with Increased Th1 and Th17 Cells and Decreased Th2 Cells
- Pinkie, the First Viable Germline Hypomorph Allele of Retinoid X Receptor Alpha, Reveals an Important Role for RXRa in Th2 Development.
- 917 Frontal fibrosing alopecia scalp profiling links Th1/Th2 and JAK3 activation with fibrosis and loss of follicular stem cells
- Influence of Gushen Shengfa Pills Combined Wuling Capsules on Th1/Th2 Cytokines in Patients with Alopecia Areata Disease
- 0085 Th1/Th2 balance, IFN-γ–MHC-I axis, and regulatory T cells define therapeutic response endotypes in alopecia areata
- Verification of the Major Metabolic Oxidation Path for the Naphthoyl Group in Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTh2) Antagonist 2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1<i>H</i>-pyrido[4,3-<i>b</i>]indol-5(2<i>H</i>)-yl)acetic Acid (Setipiprant/ACT-129968)
- Biomarkers of alopecia areata disease activity and response to corticosteroid treatment
- Alopecia Areata in Severe Atopic Dermatitis Treated With Dupilumab
- Hair eruption initiates and commensal skin microbiota aggravate adverse events of anti-EGFR therapy
- Experimental evaluation of ebastine, a second-generation anti-histamine, as a supportive medication for alopecia areata
- 544 Alopecia areata lesions show significant changes in immune and keratin biomarkers that correlate with clinical improvement with oral Janus kinase inhibitors PF-06651600 (JAK3) and PF-06700841 (TYK2/JAK1)
- Pruritus, Allergy and Autoimmunity: Paving the Way for an Integrated Understanding of Psychodermatological Diseases?
- 1322 Molecular profiling of frontal fibrosing alopecia (FFA) reveals TH1 and JAK-STAT up-regulation with no suppression of hair keratins
- Dupilumab for a 5‐year‐old child with prurigo nodularis
- Pathogenesis of paradoxical alopecia areata during dupilumab therapy: What is known and unknown
- Haarwachstum unter Dupilumab bei Alopecia areata universalis und atopischer Dermatitis
- 1313 Fzd2 controls multiple aspects of epidermal development through distinct signaling mechanisms
- 0975 Single-cell transcriptomic profiling reveals distinct immunopathogenic programs in alopecia totalis/universalis compared to patchy alopecia areata
- Table 1_A meta-analysis of chemokines in alopecia areata: recruiting immune cells toward the hair follicle.docx
- 290 Brepocitinib improves cicatricial alopecia and downregulates key T-helper biomarkers
- T helper type 2 immune response in alopecia areata
- Dupilumab Associated Progression of Alopecia Areata to Alopecia Universalis: A Case Report
- A case of dupilumab-induced psoriatic alopecia